Tranexamic Acid
Arthritis of Hip
Konkuk University Medical CenterSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
8 Active assets in the Arthritis of Hip cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ROPIVACAINE Poznan University of Medical Sciences | Phase 4 | BBB |
ROPIVACAINE Poznan University of Medical Sciences | Phase 4 | BBB |
DEXAMETHASONE Poznan University of Medical Sciences | Phase 4 | BBB |
Dfn-15 Pfizer | Phase 4 | BB |
Intravenous Dexamethsone Poznan University of Medical Sciences | Phase 4 | BB |
View all 17 →
Same molecule, other indications
Tranexamic Acid is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →